These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29769871)

  • 1. Key findings from a national enhanced HIV surveillance system: 2010 - 2012.
    Tarasuk J; Ogunnaike-Cooke S; Archibald C; MacLean R; Bennett R; Kim J; Malloch L;
    Can Commun Dis Rep; 2014 Nov; 40(18):397-407. PubMed ID: 29769871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot behavioural and biological surveillance survey for HIV and other bloodborne infections among Aboriginal people in Regina, Saskatchewan.
    Tarasuk J; Ogunnaike-Cooke S; Archibald C; Poitras M; Hennink M; Lloyd K; Faye R; Abbas Z; Bourassa C; Masching R; Bennett R; MacLean R; Malloch L; Kim J
    Can Commun Dis Rep; 2014 Nov; 40(18):388-396. PubMed ID: 29769870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National findings from the Tracks survey of people who inject drugs in Canada, Phase 4, 2017-2019.
    Tarasuk J; Zhang J; Lemyre A; Cholette F; Bryson M; Paquette D
    Can Commun Dis Rep; 2020 May; 46(5):138-148. PubMed ID: 35283692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.
    Clipman SJ; Mehta SH; Srikrishnan AK; Zook KJ; Duggal P; Mohapatra S; Shanmugam S; Nandagopal P; Kumar MS; Ogburn E; Lucas GM; Latkin CA; Solomon SS
    Elife; 2021 Aug; 10():. PubMed ID: 34342266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Findings among Indigenous participants of the Tracks survey of people who inject drugs in Canada, Phase 4, 2017-2019.
    Tarasuk J; Sullivan M; Bush D; Hui C; Morris M; Starlight T; Cholette F; Jonah L; Bryson M; Paquette D; Masching R
    Can Commun Dis Rep; 2021 Jan; 47(1):37-46. PubMed ID: 33679247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid situational assessment of people who inject drugs (PWID) in Nairobi and coastal regions of Kenya: a respondent driven sampling survey.
    Oguya FO; Kenya PR; Ongecha F; Mureithi P; Musyoka H; Muraguri N; Mundia B; Angira C; Shose M; Basheeb TA; Mohamed AA; Oyore JP; Ochieng OG; Dida GO; Abdalla S; Abdool R
    BMC Public Health; 2021 Aug; 21(1):1549. PubMed ID: 34391389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV Risk, prevention, and testing behaviors among heterosexuals at increased risk for HIV infection--National HIV Behavioral Surveillance System, 21 U.S. cities, 2010.
    Sionean C; Le BC; Hageman K; Oster AM; Wejnert C; Hess KL; Paz-Bailey G; ;
    MMWR Surveill Summ; 2014 Dec; 63(14):1-39. PubMed ID: 25522191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling.
    Zimmermann R; Marcus U; Schäffer D; Leicht A; Wenz B; Nielsen S; Santos-Hövener C; Ross RS; Stambouli O; Ratsch BA; Bannert N; Bock CT; Kücherer C; Hamouda O
    BMC Public Health; 2014 Aug; 14():845. PubMed ID: 25124485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual behaviours of men who inject drugs in northeast India.
    Kermode M; Armstrong G; Medhi GK; Humtsoe C; Langkham B; Mahanta J
    Harm Reduct J; 2015 Mar; 12():4. PubMed ID: 25889291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
    Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
    Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan.
    Deryabina AP; Patnaik P; El-Sadr WM
    Harm Reduct J; 2019 Jan; 16(1):1. PubMed ID: 30611251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
    Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
    Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
    McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
    Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of sex work on risk behaviours and their association with HIV positivity among people who inject drugs in Eastern Central Canada: cross-sectional results from an open cohort study.
    Campeau L; Blouin K; Leclerc P; Alary M; Morissette C; Blanchette C; Serhir B; Roy E;
    BMJ Open; 2018 Jan; 8(1):e019388. PubMed ID: 29391367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.